This document is a presentation by Dr. Francis Barany from Weill Cornell Medical College, discussing the use of molecular diagnostics for individualized cancer care. It covers topics such as cancer risk, early detection, individualized treatment, and recurrence prevention. The presentation highlights the limitations of current cancer detection methods and proposes solutions using advanced molecular diagnostics and microfluidic technology. It also outlines the strategic advantages of the iCareDx approach, which includes multiplexed assays and micro-fabricated devices for high-throughput processing.
documents/EFTA00614047.pdf
{}